Choong Ang Vaccine Laboratories Co., Ltd. (072020) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Choong Ang Vaccine Laboratories Co., Ltd. (072020:KRX), powered by AI.

Current Price
₩9,720
P/E Ratio
14.9
Market Cap
91.9B
Sector
Healthcare
What is the Choong Ang Vaccine Laboratories Co., Ltd. stock price forecast?

Choong Ang Vaccine Laboratories Co., Ltd. is currently trading at ₩9,720. View real-time AI analysis on Alpha Lenz.

What is Choong Ang Vaccine Laboratories Co., Ltd. insider trading activity?

View the latest insider trading data for Choong Ang Vaccine Laboratories Co., Ltd. on Alpha Lenz.

What is Choong Ang Vaccine Laboratories Co., Ltd.'s P/E ratio?

Choong Ang Vaccine Laboratories Co., Ltd.'s P/E ratio is 14.9.

Choong Ang Vaccine Laboratories Co., Ltd.

KRX · 072020
₩9,720-90(-0.92%)Market closedKRX regular session 09:00–15:30 KST
Ask about Choong Ang Vaccine Laboratories Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Choong Ang Vaccine Laboratories Co., Ltd. trades at a P/E of 14.9 (undervalued) with modest ROE of 5.9%.

Ask for details

Company Overview

Choong Ang Vaccine Laboratories Co., Ltd. (CAVAC) is a key player in the biopharmaceutical industry, with a primary focus on the development, production, and distribution of veterinary vaccines. Established in South Korea, the company specializes in biologics for livestock and pets, aiming to enhance animal health and prevent the spread of contagious diseases. CAVAC's extensive product portfolio includes vaccines for poultry, swine, cattle, and companion animals, enabling it to cater to a diverse range of clients, from large-scale farms to individual pet owners. As biosecurity becomes increasingly critical in agriculture, CAVAC's role in supplying effective and innovative veterinary solutions contributes significantly to the food safety and agribusiness sectors. The company's research-driven approach and adherence to rigorous quality standards fortify its market standing, positioning it as a strategic contributor within both local and international markets, where the demand for animal health solutions continues to grow.

CEO윤인중
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees167

Company Statistics

FY 2025

Profile

₩91,938,437,640Market Cap
₩49,068,711,760Revenue
9.46MShares Out
167Employees

Margins

48.68%Gross
26.98%EBITDA
13.20%Operating
13.36%Pre-Tax
12.55%Net

Valuation

14.93P/E
0.87P/B
1.87EV/Sales
6.69EV/EBITDA
48.51P/FCF

Growth (CAGR)

7.68%Rev 3Yr
6.20%Rev 5Yr
14.79%Op Inc 3Yr
9.96%Op Inc 5Yr
15.04%Net Inc 3Yr
14.24%Net Inc 5Yr

Returns

5.00%ROA
5.88%ROE
5.50%ROIC

Financial Health

₩10,469,640,770Cash & Cash Equivalents
₩6,977,052,820Net Debt
16.56%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Choong Ang Vaccine Laboratories Co., Ltd. (ticker: 072020) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 167 employees. Market cap is $91.9B.

The current price is ₩9,720 with a P/E ratio of 14.93x and P/B of 0.87x.

ROE is 5.88% and operating margin is 13.20%. Annual revenue is $49.1B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Choong Ang Vaccine Laboratories Co., Ltd. (072020) Stock Forecast 2026 ₩9,720 — Price, Financials & Analyst Targets | Alpha Lenz